Company news
Active Biotech Ab (OMXSTO:ACTI) news
Active Biotech Ab news releases on 6ix. Latest, Aug 20, 2026: Active Biotech Interim Report Q2 2026
Press releases & updates
Active Biotech Interim Report Q2 2026
August 20, 2026
Active Biotech announces timetable for reverse share split
May 28, 2026
Annual General Meeting of Active Biotech AB
May 20, 2026
Active Biotech Interim Report Q1 2026
May 7, 2026
Annual Report 2025 Active Biotech AB (publ)
April 1, 2026
Active Biotech Year End Report 2025
February 12, 2026
Active Biotech announces outcome in the rights issue
December 10, 2025
Active Biotech’s patent related to a pharmaceutical formulation of tasquinimod will be granted in the US
November 25, 2025
Active Biotech publishes information document regarding rights issue
November 20, 2025
Extraordinary General Meeting of Active Biotech AB
November 19, 2025
Active Biotech Interim Report Q3 2025
November 6, 2025